相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Survival and hepatitis status among Asian Americans with hepatocellular carcinoma treated without liver transplantation
Jessica P. Hwang et al.
BMC CANCER (2009)
A modified TNM-based Japan Integrated Score combined with AFP level may serve as a better staging system for early-stage predominant hepatocellular carcinoma patients
Y. -H. Yen et al.
DIGESTIVE AND LIVER DISEASE (2009)
The Value of Serum α-Fetoprotein in Predicting Tumor Recurrence After Liver Transplantation for Hepatocellular Carcinoma
Xiao Xu et al.
DIGESTIVE DISEASES AND SCIENCES (2009)
New Utility of an Old Marker: Serial α-Fetoprotein Measurement in Predicting Radiologic Response and Survival of Patients With Hepatocellular Carcinoma Undergoing Systemic Chemotherapy
Stephen L. Chan et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
Ann-Lii Cheng et al.
LANCET ONCOLOGY (2009)
The global burden of hepatitis C
Daniel Lavanchy
LIVER INTERNATIONAL (2009)
Survival of patients with hepatocellular carcinoma in cirrhosis:: a comparison of BCLC, CLIP and GRETCH staging systems
C. Camma et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2008)
Neoplastic Seeding After Radiofrequency Ablation for Hepatocellular Carcinoma
Jun Imamura et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2008)
Comparison of Seven Staging Systems in Cirrhotic Patients With Hepatocellular Carcinoma in a Cohort of Patients Who Underwent Radiofrequency Ablation With Complete Response
Alfredo Guglielmi et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2008)
Prognostic factors and treatment effects for hepatocellular carcinoma in Child C cirrhosis
K. Nouso et al.
BRITISH JOURNAL OF CANCER (2008)
A New Prognostic Score System in Patients With Advanced Hepatocellular Carcinoma Not Amendable to Locoregional Therapy Implication for Patient Selection in Systemic Therapy Trials
Thomas Yau et al.
CANCER (2008)
Prognosis and postoperative lymphocyte count in patients with hepatocellular carcinoma who received intraoperative allogenic blood transfusion: A retrospective study
S. Sugita et al.
EJSO (2008)
Preoperative predictors of vascular invasion in hepatocellular carcinoma
J. Sakata et al.
EJSO (2008)
Multicentre randomised phase III trial comparing tamoxifen alone or with transarterial lipiodol chemoembolisation for unresectable hepatocellular carcinoma in cirrhotic patients (federation francophone de cancerologie digestive 9402)
M. Doffoel et al.
EUROPEAN JOURNAL OF CANCER (2008)
Analysis of 6381 hepatocellular carcinoma patients in southern Taiwan: prognostic features, treatment outcome, and survival
Chi-Sin Changchien et al.
JOURNAL OF GASTROENTEROLOGY (2008)
Novel advancements in the management of hepatocellular carcinoma in 2008
Josep M. Llovet et al.
JOURNAL OF HEPATOLOGY (2008)
Sorafenib in advanced hepatocellular carcinoma
Josep M. Llovet et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Clinical utility of AFP-L3% measurement in North American patients with HCV-related cirrhosis
Richard K. Sterling et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2007)
Hepatocellular carcinoma: Epidemiology and molecular carcinogenesis
Hashem B. El-Serag et al.
GASTROENTEROLOGY (2007)
Clinicopathologic features of poorly differentiated hepatocellular carcinoma
Koichi Oishi et al.
JOURNAL OF SURGICAL ONCOLOGY (2007)
The utility of Lens culinaris agglutinin-reactive α-fetoprotein in the diagnosis of hepatocellular carcinoma:: Evaluation in a United States referral population
Apinya Leerapun et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2007)
Prediction of recurrence of hepatocellular carcinoma after curative ablation using three tumor markers
Ryosuke Tateishi et al.
HEPATOLOGY (2006)
Dynamic contrast-enhanced magnetic resonance imaging as an imaging biomarker
Nola Hylton
JOURNAL OF CLINICAL ONCOLOGY (2006)
Prognosis following transcatheter arterial embolization for 121 patients with unresectable hepatocellular carcinoma with or without a history of treatment
Atsushi Hiraoka et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2006)
Diagnostic and prognostic role of α-fetoprotein in hepatocellular carcinoma:: Both or neither?
F Farinati et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2006)
A randomized phase III study of doxorubicin versus cisplatin/interferon α-2b/doxorubicin/fluorouracil (PIAF) combination chemotherapy for unresectable hepatocellular carcinoma
W Yeo et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
Natural history of untreated nonsurgical hepatocellular carcinoma
YP Yeung et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2005)
α-fetoprotein response predicts survival benefits of thalidomide in advanced hepatocellular carcinoma
LT Chen et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2005)
Prognostic prediction in patients with hepatocellular carcinoma
M Sala et al.
SEMINARS IN LIVER DISEASE (2005)
Global cancer statistics, 2002
DM Parkin et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2005)
Prognostic factors for survival in patients with early-intermediate hepatocellular carcinoma undergoing nonsurgical therapy: comparison of Okuda, CLIP, and BCLC staging systems in a single Italian centre
A Grieco et al.
GUT (2005)
Reevaluation of prognostic factors for survival after liver resection in patients with hepatocellular carcinoma in a Japanese nationwide survey
I Ikai et al.
CANCER (2004)
Molecular imaging of hepatocellular carcinoma
AM Gharib et al.
GASTROENTEROLOGY (2004)
α-fetoprotein and ultrasonography screening for hepatocellular carcinoma
B Daniele et al.
GASTROENTEROLOGY (2004)
High α-fetoprotein level correlates with high stage, early recurrence and poor prognosis of hepatocellular carcinoma:: Significance of hepatitis virus infection, age, p53 and β-catenin mutations
SY Peng et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
Simple clinical prognostic model for hepatocellular carcinoma in developing countries and its validation
CK Tan et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Factors predictive of 5-year survival after transarterial chemoembolization for inoperable hepatocellular carcinoma
CB O'Suilleabhain et al.
BRITISH JOURNAL OF SURGERY (2003)
Prognostic factors in patients with hepatocellular carcinoma treated by transcatheter arterial embolization
M Ikeda et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2002)
Hepatocellular carcinoma: is current therapy really altering outcome?
PJ Johnson
GUT (2002)
The intracellular mechanism of alpha-fetoprotein promoting the proliferation of NIH 3T3 cells
MS Li et al.
CELL RESEARCH (2002)
The promoting molecular mechanism of alpha-fetoprotein on the growth of human hepatoma Bel7402 cell line
MS Li et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2002)
Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma
CM Lo et al.
HEPATOLOGY (2002)
Construction of the Chinese University Prognostic Index for hepatocellular carcinoma and comparison with the TNM staging system, the Okuda staging system, and the cancer of the Liver Italian Program staging system - A study based on 926 patients
TWT Leung et al.
CANCER (2002)
A prospective study regarding the complications of transcatheter intraarterial lipiodol chemoembolization in patients with hepatocellular carcinoma
AO Chan et al.
CANCER (2002)
Long-term survival and pattern of recurrence after resection of small hepatocellular carcinoma in patients with preserved liver function - Implications for a strategy of salvage transplantation
RTP Poon et al.
ANNALS OF SURGERY (2002)
Multicenter prospective analysis of newly diagnosed hepatocellular carcinoma with respect to the percentage of Lens culinaris agglutinin-reactive α-fetoprotein
H Oka et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2001)
Clinical management of hepatocellular carcinoma.: Conclusions of the Barcelona-2000 EASL Conference
J Bruix et al.
JOURNAL OF HEPATOLOGY (2001)
Preoperative systemic chemoimmunotherapy and sequential resection for unresectable hepatocellular carcinoma
WY Lau et al.
ANNALS OF SURGERY (2001)
Prognostic features and survival of hepatocellular carcinoma in Italy: impact of stage of disease
R Lerose et al.
EUROPEAN JOURNAL OF CANCER (2001)
Clinical characteristics and prognosis of hepatocellular carcinoma - Analaysis based on serum alpha-fetoprotein levels
P Tangkijvanich et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2000)
分享论文
